Abstract:The main purpose of this study was to prepare lipid-based self-microemulsifying drug delivery system (SMEDDS) to improve peroral bioavailability of silymarin. SMEDDS was a system consisting of silymarin, Tween 80, ethyl alcohol, and ethyl linoleate. Particle size change of the microemulsion was evaluated upon dilution with aqueous media and loading with incremental amount of silymarin. In vitro release was investigated by a dialysis or an ultrafiltration method. Results showed that release of silymarin from SMEDDS was limited, incomplete, and typical of sustained characteristics. Pharmacokinetics and bioavailability of silymarin suspension, solution, and SMEDDS were evaluated and compared in rabbits. Plasma silybin, which was treated as the representing component of silymarin, was determined by high-performance liquid chromatography. After gavage administration of silymarin suspension, plasma silybin level was very low and fell below limit of detection 4h after. As for silymarin solution and SMEDDS, double peak of maximum concentrations were observed, which was characteristic of enterohepatic circulation. Relative bioavailability of SMEDDS was dramatically enhanced in an average of 1.88- and 48.82-fold that of silymarin PEG 400 solution and suspension, respectively. It was concluded that bioavailability of silymarin was enhanced greatly by SMEDDS. Alternative mechanisms, such as improved lymphatic transport pathway, other than improved release may contribute to enhancement of bioavailability of silymarin.

Structure and Solubility of Silybin-N-Meglumine

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

A comparative study on the preparation and evaluation of solubilizing systems for silymarin

Polyamidoamine Dendrimers As Potential Drug Carriers for Enhanced Aqueous Solubility and Oral Bioavailability of Silybin

Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects

In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for silybin

A Comparative Study on the Stability of Silybin and That in Silymarin in Buffers and Biological Fluids

Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus-PVPVA complex

Liquid Chromatographic Assay of Silybin in Human Plasma and Urine

Nanostructured Lipid Carriers for Parenteral Delivery of Silybin: Biodistribution and Pharmacokinetic Studies.

Enhanced Bioavailability of Silymarin by Self-Microemulsifying Drug Delivery System

Silybin-derived Flavonolignans and Their Structure-Activity Relationships: Research Advances.

Development of Silymarin Self-Microemulsifying Drug Delivery System with Enhanced Oral Bioavailability

The Efficiency and Mechanism of N-octyl-O, N-carboxymethyl Chitosan-Based Micelles to Enhance the Oral Absorption of Silybin

Thermochemical Transition in Low Molecular Weight Substances: The Example of the Silybin Flavonoid

Hydration study of Silymarin and its ethylene glycol derivatives compounds by Monte Carlo simulation method

<i>In vitro</i>and<i>in vivo</i>evaluation of silybin nanosuspensions for oral and intravenous delivery

Metal Coordination Protocol for the Synthesis Of-2,3-dehydrosilybin and 19-O-demethyl-2,3-dehydrosilybin from Silybin and Their Antitumor Activities

Silibinin solubilization: combined effect of co-solvency and inclusion complex formation

Preparation of silymarin suspension and evaluation of its stability and release